Dariohealth Corp Stock Analysis

DarioHealth Stock Analysis Notes

About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.39. Some equities with similar Price to Book (P/B) outperform the market in the long run. DarioHealth Corp recorded a loss per share of 0.61. The entity last dividend was issued on the 18th of November 2019. The firm had 1:20 split on the 18th of November 2019. DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York. Dario Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 200 people. To learn more about DarioHealth Corp call Erez Raphael at 972 477 0637 7 or check out https://www.dariohealth.com.

DarioHealth Corp Investment Alerts

DarioHealth Corp Upcoming and Recent Events

DarioHealth Corp Thematic Classifications

DarioHealth Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 29.93 M.

DarioHealth Profitablity

The company has Profit Margin (PM) of (1.58) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.44) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.44.

Technical Drivers

As of the 21st of March, DarioHealth Corp shows the Downside Deviation of 10.67, mean deviation of 6.01, and Coefficient Of Variation of 1815.2. DarioHealth Corp technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

DarioHealth Corp Price Movement Analysis

DarioHealth Corp Insider Trading Activities

DarioHealth Corp Outstanding Bonds

DarioHealth Corp Predictive Daily Indicators

DarioHealth Corp Forecast Models

DarioHealth Corp's time-series forecasting models are one of many DarioHealth Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary DarioHealth Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how DarioHealth Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling DarioHealth shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as DarioHealth Corp. By using and applying DarioHealth Stock analysis, traders can create a robust methodology for identifying DarioHealth entry and exit points for their positions.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.